- Home
- SNTI vs ATPC Comparison
SNTI vs ATPC Comparison
Compare SNTI & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- ATPC
- Stock Information
- Founded
- SNTI 2016
- ATPC 2016
- Country
- SNTI United States
- ATPC Malaysia
- Employees
- SNTI N/A
- ATPC N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- ATPC Medical/Nursing Services
- Sector
- SNTI Health Care
- ATPC Health Care
- Exchange
- SNTI Nasdaq
- ATPC Nasdaq
- Market Cap
- SNTI 53.6M
- ATPC 63.0M
- IPO Year
- SNTI N/A
- ATPC N/A
- Fundamental
- Price
- SNTI $2.05
- ATPC $1.26
- Analyst Decision
- SNTI Strong Buy
- ATPC
- Analyst Count
- SNTI 4
- ATPC 0
- Target Price
- SNTI $8.75
- ATPC N/A
- AVG Volume (30 Days)
- SNTI 97.8K
- ATPC 34.5K
- Earning Date
- SNTI 11-13-2025
- ATPC 11-13-2025
- Dividend Yield
- SNTI N/A
- ATPC N/A
- EPS Growth
- SNTI N/A
- ATPC N/A
- EPS
- SNTI N/A
- ATPC N/A
- Revenue
- SNTI N/A
- ATPC $1,484,905.00
- Revenue This Year
- SNTI N/A
- ATPC N/A
- Revenue Next Year
- SNTI $150.00
- ATPC N/A
- P/E Ratio
- SNTI N/A
- ATPC N/A
- Revenue Growth
- SNTI N/A
- ATPC 9.66
- 52 Week Low
- SNTI $1.26
- ATPC $0.90
- 52 Week High
- SNTI $16.94
- ATPC $2.93
- Technical
- Relative Strength Index (RSI)
- SNTI 56.53
- ATPC 42.00
- Support Level
- SNTI $1.44
- ATPC $1.25
- Resistance Level
- SNTI $2.16
- ATPC $1.34
- Average True Range (ATR)
- SNTI 0.18
- ATPC 0.08
- MACD
- SNTI 0.02
- ATPC -0.01
- Stochastic Oscillator
- SNTI 84.03
- ATPC 7.41
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.